Skip Navigation

Cardiovascular Research 2000 47(4):715-725; doi:10.1016/S0008-6363(00)00140-1
© 2000 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Maitra, N.
Right arrow Articles by Morkin, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maitra, N.
Right arrow Articles by Morkin, E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2000, European Society of Cardiology

Expression of {alpha} and β integrins during terminal differentiation of cardiomyocytes

Niranjan Maitraa, Irwin L. Flinka,*, Joseph J. Bahla and Eugene Morkina,b

aUniversity of Arizona Sarver Heart Center and Department of Medicine, 1501 N. Campbell Avenue, University of Arizona, Tucson, AZ 85724, USA
bDepartment of Physiology and Pharmacology, 1501 N. Campbell Avenue, University of Arizona, Tucson, AZ 85724, USA

* Corresponding author. Tel.: +1-520-626-6639; fax: +1-520-626-8408 iflink{at}u.arizona.edu

Background: In the myocardium, myocyte cell division is irreversibly blocked shortly after birth. The signal that initiates cell cycle withdrawal is unknown. The purpose of this study was to relate changes in expression of β1 integrin and its associated {alpha} subunits to cardiomyocyte cell cycle progression during the fetal-to-neonatal developmental transition in rat. Methods and results: The developmental expression pattern and function of β1 integrin and several of its associated {alpha} subunits were examined using reverse transcription (RT) polymerase chain reaction (PCR) and β1 blocking antibodies. During the fetal to neonatal transition, a dramatic shift occurred in the levels of β1 and {alpha} isoforms. At the 17-day fetal stage only β1A was present, which remained relatively constant until immediately after birth then decreased by 30% at the adult stage. By contrast, β1D appeared at fetal day 18, increased at neonatal day 2, and afterwards remained constant. This resulted in a ratio of β1A to β1D of about 1:1 in the adult heart. The integrin β1-associated subunits, {alpha}3, {alpha}6, and {alpha}7, were expressed at extremely low levels in 17-day fetal cardiomyocytes. After birth {alpha}3 and {alpha}6 transiently increased at the 2-day neonatal stage, while {alpha}7 isoforms B, C, and X2 progressively increased to the adult stage. Unlike skeletal muscle cells, fluorescence-activated cell sorting analysis (FACS) showed no down regulation of the {alpha}5β1 fibronectin receptor during cell cycle withdrawal. Treatment of cultured cardiomyocytes with β1 blocking antibody inhibited the cell cycle in fetal but not in neonatal cells. Conclusion: These results suggest that progression through the cardiomyocyte cell cycle may be dependent upon cell attachment via integrin β1 and correlate with changes that occur in β1 spliced variants and their respective {alpha} isoforms.

KEYWORDS Cell culture/isolation; Developmental biology; Extracellular matrix; Myocytes


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Circ. Res.Home page
S. M. Dallabrida, N. Ismail, J. R. Oberle, B. E. Himes, and M. A. Rupnick
Angiopoietin-1 Promotes Cardiac and Skeletal Myocyte Survival Through Integrins
Circ. Res., March 4, 2005; 96(4): e8 - e24.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. S Ross
Molecular and mechanical synergy: cross-talk between integrins and growth factor receptors
Cardiovasc Res, August 15, 2004; 63(3): 381 - 390.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. Communal, F. Huq, D. Lebeche, C. Mestel, J. K. Gwathmey, and R. J. Hajjar
Decreased Efficiency of Adenovirus-Mediated Gene Transfer in Aging Cardiomyocytes
Circulation, March 4, 2003; 107(8): 1170 - 1175.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
P. Stawowy, F. Blaschke, P. Pfautsch, S. Goetze, F. Lippek, B. Wollert-Wulf, E. Fleck, and K. Graf
Increased myocardial expression of osteopontin in patients with advanced heart failure
Eur J Heart Fail, March 1, 2002; 4(2): 139 - 146.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
R. S. Ross and T. K. Borg
Integrins and the Myocardium
Circ. Res., June 8, 2001; 88(11): 1112 - 1119.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. Hescheler and B. K. Fleischmann
Integrins and cell structure: powerful determinants of heart development and heart function
Cardiovasc Res, September 1, 2000; 47(4): 645 - 647.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.